Cargando…
Platelet/lymphocyte ratio and risk of in-hospital mortality in patients with ST-elevated myocardial infarction
BACKGROUND: Platelet-to-lymphocyte ratio (PLR) is a new prognostic marker in coronary artery disease. We aimed to evaluate the relationship between PLR and in-hospital mortality in patients with ST-elevated acute myocardial infarction (AMI). MATERIAL/METHODS: The present study included 636 patients...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3999159/ https://www.ncbi.nlm.nih.gov/pubmed/24751474 http://dx.doi.org/10.12659/MSM.890152 |
_version_ | 1782313472280756224 |
---|---|
author | Temiz, Ahmet Gazi, Emine Güngör, Ömer Barutçu, Ahmet Altun, Burak Bekler, Adem Binnetoğlu, Emine Şen, Hacer Güneş, Fahri Gazi, Sabri |
author_facet | Temiz, Ahmet Gazi, Emine Güngör, Ömer Barutçu, Ahmet Altun, Burak Bekler, Adem Binnetoğlu, Emine Şen, Hacer Güneş, Fahri Gazi, Sabri |
author_sort | Temiz, Ahmet |
collection | PubMed |
description | BACKGROUND: Platelet-to-lymphocyte ratio (PLR) is a new prognostic marker in coronary artery disease. We aimed to evaluate the relationship between PLR and in-hospital mortality in patients with ST-elevated acute myocardial infarction (AMI). MATERIAL/METHODS: The present study included 636 patients with ST-elevated AMI. The study population was divided into tertiles based on their admission PLR. Patients having values in the third tertile was defined as the high PLR group (n=212) and those having values in the lower 2 tertiles were defined as the low PLR group (n=424). RESULTS: Risk factors of coronary artery disease and treatments administered during the in-hospital period were similar between the groups. Male patient ratio was found to be lower in the high PLR group (73% vs. 82.8%, p=0.004). In-hospital mortality was increased in the high PLR group when compared to the low PLR group (12.7% vs. 5.9%, p=0.004). The PLR >144 was found to be an independent predictor of in-hospital cardiovascular mortality (HR: 2.16, 95% CI: 1.16–4.0, p=0.014). CONCLUSIONS: This study showed that PLR is an independent predictor of cardiovascular mortality in patients with ST-elevated AMI. |
format | Online Article Text |
id | pubmed-3999159 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | International Scientific Literature, Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-39991592014-04-25 Platelet/lymphocyte ratio and risk of in-hospital mortality in patients with ST-elevated myocardial infarction Temiz, Ahmet Gazi, Emine Güngör, Ömer Barutçu, Ahmet Altun, Burak Bekler, Adem Binnetoğlu, Emine Şen, Hacer Güneş, Fahri Gazi, Sabri Med Sci Monit Clinical Research BACKGROUND: Platelet-to-lymphocyte ratio (PLR) is a new prognostic marker in coronary artery disease. We aimed to evaluate the relationship between PLR and in-hospital mortality in patients with ST-elevated acute myocardial infarction (AMI). MATERIAL/METHODS: The present study included 636 patients with ST-elevated AMI. The study population was divided into tertiles based on their admission PLR. Patients having values in the third tertile was defined as the high PLR group (n=212) and those having values in the lower 2 tertiles were defined as the low PLR group (n=424). RESULTS: Risk factors of coronary artery disease and treatments administered during the in-hospital period were similar between the groups. Male patient ratio was found to be lower in the high PLR group (73% vs. 82.8%, p=0.004). In-hospital mortality was increased in the high PLR group when compared to the low PLR group (12.7% vs. 5.9%, p=0.004). The PLR >144 was found to be an independent predictor of in-hospital cardiovascular mortality (HR: 2.16, 95% CI: 1.16–4.0, p=0.014). CONCLUSIONS: This study showed that PLR is an independent predictor of cardiovascular mortality in patients with ST-elevated AMI. International Scientific Literature, Inc. 2014-04-22 /pmc/articles/PMC3999159/ /pubmed/24751474 http://dx.doi.org/10.12659/MSM.890152 Text en © Med Sci Monit, 2014 This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License |
spellingShingle | Clinical Research Temiz, Ahmet Gazi, Emine Güngör, Ömer Barutçu, Ahmet Altun, Burak Bekler, Adem Binnetoğlu, Emine Şen, Hacer Güneş, Fahri Gazi, Sabri Platelet/lymphocyte ratio and risk of in-hospital mortality in patients with ST-elevated myocardial infarction |
title | Platelet/lymphocyte ratio and risk of in-hospital mortality in patients with ST-elevated myocardial infarction |
title_full | Platelet/lymphocyte ratio and risk of in-hospital mortality in patients with ST-elevated myocardial infarction |
title_fullStr | Platelet/lymphocyte ratio and risk of in-hospital mortality in patients with ST-elevated myocardial infarction |
title_full_unstemmed | Platelet/lymphocyte ratio and risk of in-hospital mortality in patients with ST-elevated myocardial infarction |
title_short | Platelet/lymphocyte ratio and risk of in-hospital mortality in patients with ST-elevated myocardial infarction |
title_sort | platelet/lymphocyte ratio and risk of in-hospital mortality in patients with st-elevated myocardial infarction |
topic | Clinical Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3999159/ https://www.ncbi.nlm.nih.gov/pubmed/24751474 http://dx.doi.org/10.12659/MSM.890152 |
work_keys_str_mv | AT temizahmet plateletlymphocyteratioandriskofinhospitalmortalityinpatientswithstelevatedmyocardialinfarction AT gaziemine plateletlymphocyteratioandriskofinhospitalmortalityinpatientswithstelevatedmyocardialinfarction AT gungoromer plateletlymphocyteratioandriskofinhospitalmortalityinpatientswithstelevatedmyocardialinfarction AT barutcuahmet plateletlymphocyteratioandriskofinhospitalmortalityinpatientswithstelevatedmyocardialinfarction AT altunburak plateletlymphocyteratioandriskofinhospitalmortalityinpatientswithstelevatedmyocardialinfarction AT bekleradem plateletlymphocyteratioandriskofinhospitalmortalityinpatientswithstelevatedmyocardialinfarction AT binnetogluemine plateletlymphocyteratioandriskofinhospitalmortalityinpatientswithstelevatedmyocardialinfarction AT senhacer plateletlymphocyteratioandriskofinhospitalmortalityinpatientswithstelevatedmyocardialinfarction AT gunesfahri plateletlymphocyteratioandriskofinhospitalmortalityinpatientswithstelevatedmyocardialinfarction AT gazisabri plateletlymphocyteratioandriskofinhospitalmortalityinpatientswithstelevatedmyocardialinfarction |